Rare complications of multikinase inhibitor treatment

OBJECTIVE: The advent of multikinase inhibitor (MKI) therapy has led to a radical change in the treatment of patients with advanced thyroid carcinoma. The aim of this manuscript is to communicate rare adverse events that occurred in less than 5% of patients in clinical trials in a subset of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitoia, Fabián, Schmidt, Angélica, Bueno, Fernanda, Abelleira, Erika, Jerkovich, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118667/
https://www.ncbi.nlm.nih.gov/pubmed/30624504
http://dx.doi.org/10.20945/2359-3997000000090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118667/
https://www.ncbi.nlm.nih.gov/pubmed/30624504
http://dx.doi.org/10.20945/2359-3997000000090

Ejemplares similares